×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
CSLLY – csl ltd sp/adr (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
CSLLY
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
12/11
11:28 am
cslly
Heavenly Garage Doors & Gates Announces Expand Mobile Service Network To Support Rising Demand for Garage Door, Gate, and Fence Repairs Across Los Angeles [Yahoo! Finance]
Low
Report
Heavenly Garage Doors & Gates Announces Expand Mobile Service Network To Support Rising Demand for Garage Door, Gate, and Fence Repairs Across Los Angeles [Yahoo! Finance]
12/7
12:01 pm
cslly
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
Low
Report
Data Published in the New England Journal of Medicine Confirm the Long-term Durability and Safety of HEMGENIX® (etranacogene dezaparvovec-drlb) Over Five Years
12/4
01:00 am
cslly
LA County contractor accused of defrauding families in home remodeling projects [CBS News]
Low
Report
LA County contractor accused of defrauding families in home remodeling projects [CBS News]
11/20
06:02 am
cslly
CSL (OTCMKTS:CSLLY) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Low
Report
CSL (OTCMKTS:CSLLY) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
11/19
08:22 am
cslly
CSL to pump $1.5bn into US plasma supply chain [Yahoo! Finance]
Low
Report
CSL to pump $1.5bn into US plasma supply chain [Yahoo! Finance]
11/18
09:06 am
cslly
Karoo Health Appoints Healthtech and Physician Leader Dr. Aneesh Pakala as Chief Medical Officer [Yahoo! Finance]
Medium
Report
Karoo Health Appoints Healthtech and Physician Leader Dr. Aneesh Pakala as Chief Medical Officer [Yahoo! Finance]
11/10
05:07 am
cslly
Coastal Community Builders Wins Dual Gold Awards at the 2026 MUSE Creative Awards [Yahoo! Finance]
High
Report
Coastal Community Builders Wins Dual Gold Awards at the 2026 MUSE Creative Awards [Yahoo! Finance]
10/26
11:23 pm
cslly
CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)
Low
Report
CSL Honoured as Overall Winner of the 2025 Facility of the Year Awards by the International Society for Pharmaceutical Engineering (ISPE)
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/13
Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at Jefferies Financial Group Inc from a "hold" rating to a "buy" rating.
22.0%
3/9 Australian shares dip into bear market territory [Reuters] 7.0%
4/8 Australia's CSL stands by profit guidance due to strong demand for blood products [Reuters] 6.4%
4/2 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 5.5%
4/27 Australian shares close higher on global stimulus hopes [Reuters] 3.7%
8/13 Australia shares join global rally as miners bounce, CSL gains [Reuters] 3.5%
2/18 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. 3.3%
1/10 Researchers decipher a new way that immune cells detect infections and cancers 2.9%
1/27 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.8%
10/14 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 2.5%
3/9 Australian shares dip into bear market territory [Reuters] 7.0%
4/8 Australia's CSL stands by profit guidance due to strong demand for blood products [Reuters] 6.4%
4/2 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at ValuEngine from a "sell" rating to a "hold" rating. 5.5%
4/27 Australian shares close higher on global stimulus hopes [Reuters] 3.7%
8/13 Australia shares join global rally as miners bounce, CSL gains [Reuters] 3.5%
2/18 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Morgan Stanley from an "overweight" rating to an "equal weight" rating. 3.3%
1/10 Researchers decipher a new way that immune cells detect infections and cancers 2.9%
1/27 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.8%
10/14 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 2.5%
TOP News Decliners
2/24
Seqirus Receives FDA Approval for FLUAD® QUADRIVALENT (Influenza Vaccine, Adjuvanted) for Adults 65 Years and Older
-5.5%
4/21 CSL Behring Announces Results from Three Analyses of Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) in Primary Immunodeficiency (PI) -4.1%
12/9 HIZENTRA® (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) -1.4%
11/15 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -1.2%
10/7 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -0.8%
2/17 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $124.00 price target on the stock. -0.7%
9/4 Australian shares end lower on global growth worries, but NZ rises [Reuters] -0.3%
7/1 CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019 -0.3%
4/9 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $110.00 price target on the stock. -0.3%
1/21 Forbes Magazine Ranks CSL Behring Among Best Employers for Diversity -0.2%
4/21 CSL Behring Announces Results from Three Analyses of Hizentra® (Immune Globulin Subcutaneous [Human] 20% Liquid) in Primary Immunodeficiency (PI) -4.1%
12/9 HIZENTRA® (Immune Globulin Subcutaneous [Human] 20% Liquid) Receives Orphan-Drug Exclusivity for the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) -1.4%
11/15 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -1.2%
10/7 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. -0.8%
2/17 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $124.00 price target on the stock. -0.7%
9/4 Australian shares end lower on global growth worries, but NZ rises [Reuters] -0.3%
7/1 CSL Behring Delivers on its Promise to Advance Bleeding Disorder Treatment Research by Supporting 16 Data Presentations at ISTH 2019 -0.3%
4/9 Commonwealth Bank of Australia (OTCMKTS: CSLLY) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $110.00 price target on the stock. -0.3%
1/21 Forbes Magazine Ranks CSL Behring Among Best Employers for Diversity -0.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: